Credit and Counterparty Risk VP (523ABD8)

Referment is working with a specialist UK bank that provides correspondent banking, FX and cross-border payments into emerging and frontier markets.

The role combines strong analytical capability with technical leadership, independent judgement and stakeholder engagement. The successful candidate will provide expert challenge across a broad range of counterparties, products and jurisdictions, whilst mentoring junior colleagues and contributing to strategic initiatives across the risk function. The role has a particular focus on counterparty credit risk arising from treasury and FX activities, including derivatives, and will play an important role in supporting the organisation's evolving derivatives, exposure measurement and portfolio risk management capabilities.

Requirements

Qualifications

• Bachelor's degree or equivalent in Finance, Economics, Accounting, Mathematics or another relevant discipline.
• Relevant professional qualification (e.g. CFA, PRM, FRM, ACA, ACCA) desirable. Experience
• Significant experience within Credit Risk, Counterparty Credit Risk, Financial Institutions Risk, Treasury Risk or a related discipline within banking or financial services.
• Strong credit analytical capability and demonstrated experience assessing financial institutions, sovereigns, corporates or other complex counterparties.
• Demonstrable experience monitoring and managing credit portfolios, including early warning indicators, watchlist processes, concentration analysis and risk reporting.
• Good understanding of banking products from a credit risk perspective, including payments, treasury products, FX and derivatives.
• Experience of counterparty credit risk arising from treasury products, FX and/or derivatives would be highly desirable. Exposure to exposure measurement methodologies, collateral arrangements or netting frameworks would be advantageous.
• Experience presenting and defending risk recommendations to senior stakeholders and governance committees.
• Demonstrated ability to coach, mentor and support the development of junior colleagues.
• Strong stakeholder management and communication skills, with the ability to influence outcomes across functions and levels of seniority.
• Strong analytical, problem-solving and judgement capabilities.
• Experience using risk systems, Excel, portfolio monitoring and business intelligence tools (e.g.

Role Responsibilities Credit & Counterparty Risk

• Lead the preparation and review of credit applications, annual reviews and risk assessments across a broad range of counterparties, including Financial Institutions, Central Banks, NBFIs, Corporates, NGOs and International Development Organisations.
• Provide clear, balanced and commercially aware recommendations to approving authorities, exercising independent judgement on complex, material or higher-risk transactions.
• Act as a senior technical mentor, ensuring consistency, quality and robustness of risk assessments produced within the team.
• Support transaction structuring discussions and provide independent challenge on credit, counterparty and country risk considerations.
• Contribute to the ongoing development of credit methodologies, risk appetite frameworks and underwriting standards.

Portfolio Monitoring & Risk Oversight

• Lead the ongoing monitoring of the organisation's credit and counterparty risk portfolio, identifying emerging risks, adverse trends and concentrations.
• Monitor counterparty performance, financial condition, limit utilisation and early warning indicators, ensuring that material issues are identified and escalated appropriately.
• Oversee watchlist and heightened monitoring processes for higher-risk counterparties and exposures.
• Perform portfolio analysis to identify sector, geographical, product and counterparty concentrations.
• Lead the production and interpretation of portfolio reporting, management information and risk insights for senior management and governance committees.
• Recommend risk mitigation actions where deterioration in credit quality or adverse developments are identified.

#Referment

#J-18808-Ljbffr